Advertisement

A new genetic test can help distinguish between aggressive and low-risk forms of prostate cancer, which could enable many men to delay or forgo surgery to treat it. Over 220,000 men in the U.S. are diagnosed with prostate cancer anually. Ron Winslow reports on Lunch Break.

Advertisement
Advertisement